A unique magnesium supplement called Magtein® (magnesium L-threonate) has been shown to increase brain levels of magnesium and functional neuronal terminals compared to other magnesium supplements including magnesium citrate, gluconate, malate and glycinate in animal studies. Furthermore, Magtein® also has been shown to prevent synaptic loss and reverse cognitive deficits in Alzheimer’s disease animal models. In patients with cognitive impairment, Magtein® was shown to significantly improve overall cognitive ability and reverse the equivalent of 9 years of brain aging. Magtein® has also been shown to improve the MMSE score in patients with mild to moderate probable Alzheimer’s disease.
To learn more about this ingredient—including its mechanism of action, six functional categories, its synergies with other ingredients, and the clinical trials backing it—download the PDF, for free,by clicking here.
This content paid for and provided by AIDP.
